CN105130989A - 2-fluoroadenine synthetic method - Google Patents

2-fluoroadenine synthetic method Download PDF

Info

Publication number
CN105130989A
CN105130989A CN201510620892.XA CN201510620892A CN105130989A CN 105130989 A CN105130989 A CN 105130989A CN 201510620892 A CN201510620892 A CN 201510620892A CN 105130989 A CN105130989 A CN 105130989A
Authority
CN
China
Prior art keywords
fluoroadenine
pyranyl
purine
chloro
synthetic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510620892.XA
Other languages
Chinese (zh)
Other versions
CN105130989B (en
Inventor
夏然
孙莉萍
陈磊山
丰贵鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinxiang University
Original Assignee
Xinxiang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinxiang University filed Critical Xinxiang University
Priority to CN201510620892.XA priority Critical patent/CN105130989B/en
Publication of CN105130989A publication Critical patent/CN105130989A/en
Application granted granted Critical
Publication of CN105130989B publication Critical patent/CN105130989B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a 2-fluoroadenine synthetic method. The 2-fluoroadenine synthetic method comprises the steps of taking cheap 6-chloropurine as a raw material, and carrying out tetrahydropyranyl protection on a 9-position NH; then enabling a product obtained in step one to react with trifluoromethanesulfonic anhydride, and introducing nitryl at 2-position; continuously enabling a product obtained in step two to react with NH4F, and removing tetrahydropyranyl while converting the nitryl into fluorine atoms; finally, converting the 6-position fluorine atom into amidogen in methanol solution which is saturated by ammonia gas, thus obtaining 2-fluoroadenine, wherein the total yield is 58 percent. According to the2-fluoroadenine synthetic method disclosed by the invention, the raw material is cheap and easy to obtain, a reagent which has expensive cost and is toxic and harmful is prevented from being used, risky and corrosive operating steps are prevented from being used, and the yield is not obviously reduced when the reaction scale is enlarged to be 200g; a new synthetic path is provided for synthesizing of the 2-fluoroadenine, and a potential application prospect is obtained.

Description

A kind of 2-fluoroadenine synthetic method
Technical field
The present invention relates to the synthetic method that medicine intermediate is new, be specifically related to a kind of 2-fluoroadenine synthetic method.
Background technology
2-fluoroadenine (1) is a kind of important medicine intermediate, and be widely used in the synthesis of anti-viral nucleoside medicine fludarabine, fludarabine phosphate, 2-fluorine adenosine and other nucleoside medicines, domestic and international demand is huge.Its traditional synthetic method is all take diazotization reaction as committed step.As taken 2,6-diaminopurine as raw material, obtained by fluoroboric acid diazotization reaction, yield is 0.7%-6.0% only.After descendant improves, with anhydrous hydrogen fluoride as fluorine source, yield brings up to 22%, but anhydrous hydrogen fluoride corrodibility is strong, operation inconvenience, the large [CalleyN.Eaton of environmental pollution, GeorgeH.DennyJr.Synthesisof2-fluoroadenine.J.Org.Chem., 1969,34 (3), 747 – 748].The report such as Chen Jianbing, from 2-amido-6-chloropurine, synthesizes 2 amino-6-nitrine purine, then at fluoroboric acid and NaNO by azido reaction 2there is schiemann reaction under effect, finally azido-reduction is obtained 2-fluoroadenine, yield 39% (Wang Jiangjie, Sun little Yan, Chen Jianbing. the novel method of synthesis 2-fluoroadenine. synthetic chemistry, 2007,15,506-507.).Diazotization reaction explosive, the sodiumazide used has severe toxicity, operation inconvenience, the synthesis step of 2,6-diaminopurine or 2-amido-6-chloropurine is many, and such as [Chen Wenhua. the synthesis of Famciclovir. chemical reagent, 2006,28 (28): 185-186.], cost is high, and these shortcomings limit the expansion of reaction scale.
Summary of the invention
In order to solve the deficiencies in the prior art, the invention provides a kind of 2-fluoroadenine synthetic method.
Technical scheme of the present invention is: a kind of 2-fluoroadenine synthetic method, is characterized in that, comprise the following steps, step 1: take 6-chloropurine as Material synthesis 6-chloro-9-pyranyl purine; Step 2: the 6-that step 1 obtains chloro-9-pyranyl purine and trifluoromethanesulfonic acid anhydride reactant, introduces nitro at 2 and obtains the chloro-2-nitro of 6--9-pyranyl purine; Step 3: by the chloro-2-nitro of the 6--9-pyranyl purine that obtains in step 2 and NH 4while nitro is converted into fluorine atom by F reaction, deprotection base; 6 chlorine atoms are converted into amino, obtain 2-fluoroadenine by step 4: the fluoro-6-chloropurine of the 2-finally step 3 obtained is ammonia solution in the methanol solution saturated by ammonia.
Further improvement of the present invention comprises:
Described protecting group is THP trtrahydropyranyl.
Step 2 specifically comprises: tetrabutyl ammonium nitrate (10.1g, 33mmol) be dissolved in 50mL anhydrous methylene chloride, be cooled to 0 DEG C, add trifluoromethanesulfanhydride anhydride (4.6mL, 33mmol), stir 20 minutes, add freshly prepd 6-chloro-9-pyranyl purine (3, 5.24g, 22mmol), remain on 0 DEG C, react 5 hours, add 100mL saturated sodium bicarbonate solution, stir, separate organic phase, aqueous phase methylene dichloride (20mL × 2) extracts, collect organic phase, dry, removal of solvent under reduced pressure, obtain pale yellow oil, be the chloro-2-nitro of 6--9-pyranyl purine (4).
Step 3 specifically comprises: the chloro-2-nitro of 6--9-pyranyl purine (, 4,5.6g, 20mmol) and NH 4f (1.1g, 30mmol) joins in DMF (50mL), stirring at room temperature, react 10 hours, activated carbon decolorizing, removal of solvent under reduced pressure, the thick substances water recrystallization obtained, obtains white powder, is the fluoro-6-chloropurine of 2-(5).
Step 4 specifically comprises: the fluoro-6-chloropurine (5 of 2-, 10g, 58mmol), join 100mL by the saturated methanol solution of ammonia, be heated to 50 DEG C of reactions 10 hours, cooling, activated carbon decolorizing, removal of solvent under reduced pressure, obtain oily matter, use water recrystallization, obtain white solid, be 2-fluoroadenine (1).
The present patent application for raw material, carries out THP trtrahydropyranyl protection to 9 NH with the 6-chloropurine of cheapness, then with trifluoromethanesulfonic acid anhydride reactant, introduces nitro at 2, and NH 4nitro is converted into fluorine atom by F reaction, removes THP trtrahydropyranyl simultaneously, finally in the methanol solution saturated by ammonia, 6 chlorine atoms is converted into amino, obtains 2-fluoroadenine, total recovery 58%.Present method cheaper starting materials is easy to get, and avoids use expensive and poisonous and hazardous reagent, avoid using dangerous and corrosive operation steps, and when reaction scale expands 200g scale to, yield is without obvious decline.The present patent application is that the synthesis of 2-fluoroadenine provides a new route of synthesis, has potential application prospect.Synthetic route is as follows:
。Wherein, the prior art of synthesis 6-chloro-9-pyranyl purine 3 is specially (PurineNucleosides.I.TheSynthesisofCertain6-Substituted-9-(tetrahydro-2-pyranyl)-purinesasModelsofPurineDeoxynucleosides [J] .RolandK.Robins, ErikF.Godefroi, EdwardC.Taylor, LelandR.Lewis, andAlvinJackson.J.Am.Chem.Soc., 1961,83 (11), 2574-2579.) synthetic method recorded in.
Embodiment
Below in conjunction with embodiment, the present invention is elaborated.
Embodiment 1
A kind of 2-fluoroadenine synthetic method, is characterized in that, comprise the following steps, step 1: take 6-chloropurine as Material synthesis 6-chloro-9-pyranyl purine; Step 2: the 6-that step 1 obtains chloro-9-pyranyl purine and trifluoromethanesulfonic acid anhydride reactant, introduces nitro at 2, obtains the chloro-2-nitro of 6--9-pyranyl purine; Step 3: by the chloro-2-nitro of the 6--9-pyranyl purine that obtains in step 2 and NH 4nitro is converted into fluorine atom by F reaction, simultaneously deprotection base; 6 chlorine atoms are converted into amino, obtain 2-fluoroadenine by step 4: the fluoro-6-chloropurine of the 2-finally step 3 obtained is ammonia solution in the methanol solution saturated by ammonia.
Embodiment 2
Key instrument and reagent
AC400 type nuclear magnetic resonance analyser (CDCl 3or DMSO-d 6for solvent, TMS is interior mark, Bruker company); Kofler micro melting point apparatus, thermometer is not calibrated; 6-chloropurine (Xinxiang Tuoxin Biochemical Co., Ltd.); Agents useful for same is analytical pure.Synthetic route is as follows:
Synthetic method
The synthesis of 6-chloro-9-pyranyl purine (3)
According to document synthesis, yield 96%, product fusing point, 1hNMR data conform to bibliographical information (PurineNucleosides.I.TheSynthesisofCertain6-Substituted-9-(tetrahydro-2-pyranyl)-purinesasModelsofPurineDeoxynucleosides.RolandK.Robins, ErikF.Godefroi, EdwardC.Taylor, LelandR.Lewis, andAlvinJackson.J.Am.Chem.Soc., 1961,83 (11), 2574-2579.).
The synthesis of the chloro-2-nitro of 6--9-pyranyl purine (4)
Tetrabutyl ammonium nitrate (10.1g, 33mmol) be dissolved in anhydrous methylene chloride (50mL), be cooled to 0 DEG C, add trifluoromethanesulfanhydride anhydride (4.6mL, 33mmol), stir 20 minutes, add freshly prepd 6-chloro-9-pyranyl purine (3, 5.24g, 22mmol), remain on 0 DEG C, react 5 hours, add saturated sodium bicarbonate (100mL) solution, stir, separate organic phase, aqueous phase methylene dichloride (20mL × 2) extracts, collect organic phase, dry, removal of solvent under reduced pressure, obtain pale yellow oil, be target product 4, yield 85%.
The synthesis of the fluoro-6-chloropurine of 2-(5)
The chloro-2-nitro of 6--9-pyranyl purine (4,5.6g, 20mmol) and NH 4f (1.1g, 30mmol) join N, in dinethylformamide (50mL), stirring at room temperature, reacts 10 hours, activated carbon decolorizing, removal of solvent under reduced pressure, the thick substances water recrystallization obtained, obtains white powder, be the fluoro-6-chloropurine of 2-(5), yield 83%.
2-fluoroadenine (1) synthesizes
The fluoro-6-chloropurine of 2-(5,10g, 58mmol), join by the saturated methanol solution (100mL) of ammonia, be heated to 50 DEG C of reactions 10 hours, cooling, activated carbon decolorizing, removal of solvent under reduced pressure, obtain oily matter, use water recrystallization, obtain white solid, be 2-fluoroadenine (1), yield 86%.
Described protecting group is THP trtrahydropyranyl.6-chloropurine polarity is comparatively large, and solubleness is limited in organic solvent, and 9 NH can affect nitration reaction simultaneously, so, 9 NH must be protected in denitrification step.Contriver examines multiple protecting group through lot of experiments, but all undesirable, and as benzyl is difficult to remove, ethanoyl not easily with 9 NH reaction, trimethyl silicon basedly easily takes off in nitration reaction process.Finally we filter out THP trtrahydropyranyl, and it both can increase its solubleness in organic solvent, can relatively easily slough again.In fluoro-reaction, due to the acidity of tetrabutyl ammonium fluoride, deprotection and fluoro can one pot complete, shorten reactions steps.
Reaction scale is on the impact of yield
The synthesis of 6-chloro-9-pyranyl purine (3) and the fluoro-6-chloropurine of 2-6 ammonia solutions relatively easily can realize the synthesis of feather weight in laboratory, technical difficulty is little.Committed step is the nitrated and fluoro-reaction of 6-chloro-9-pyranyl purine.Reaction scale that is nitrated and fluoro is examined or check, the results are shown in Table 1.
Table 1 differential responses scale is on the impact of yield
As shown in Table 1, reaction scale is extended to ten grams of levels to hectogram level, after the separating-purifying of routine, nitrated yield is reduced to 80%, and when reaction scale reaches 200g, the yield of fluoro step still can reach 83%, add the recycling to mother liquor, yield also can increase to some extent, so the applicability of whole piece route is very strong generally.
The present patent application for raw material, carries out THP trtrahydropyranyl protection to 9 NH with the 6-chloropurine of cheapness, then with trifluoromethanesulfonic acid anhydride reactant, introduces nitro at 2, and NH 4nitro is converted into fluorine atom by F reaction, removes THP trtrahydropyranyl simultaneously, finally in the methanol solution saturated by ammonia, 6 chlorine atoms is converted into amino, obtains 2-fluoroadenine, total recovery 58%.Present method cheaper starting materials is easy to get, and avoids use expensive and poisonous and hazardous reagent, avoid using dangerous and corrosive operation steps, and when reaction scale expands 200g scale to, yield is without obvious decline.The present patent application is that the synthesis of 2-fluoroadenine provides a new route of synthesis, has potential application prospect.
More than show and describe ultimate principle of the present invention and principal character and advantage of the present invention.The technician of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and specification sheets just illustrates principle of the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.

Claims (5)

1. a 2-fluoroadenine synthetic method, is characterized in that, comprises the following steps,
Step 1: take 6-chloropurine as Material synthesis 6-chloro-9-pyranyl purine;
Step 2: the 6-that step 1 obtains chloro-9-pyranyl purine and trifluoromethanesulfonic acid anhydride reactant, introduces nitro at 2, obtains the chloro-2-nitro of 6--9-pyranyl purine;
Step 3: by the chloro-2-nitro of the 6--9-pyranyl purine that obtains in step 2 and NH 4f reacts, while nitro is converted into fluorine atom, and deprotection base;
6 chlorine atoms are converted into amino, obtain 2-fluoroadenine by step 4: the fluoro-6-chloropurine of the 2-finally step 3 obtained is ammonia solution in the methanol solution saturated by ammonia.
2. a kind of 2-fluoroadenine synthetic method according to claim 1, it is characterized in that, described protecting group is THP trtrahydropyranyl.
3. a kind of 2-fluoroadenine synthetic method according to claim 1, it is characterized in that, step 2 specifically comprises: tetrabutyl ammonium nitrate (10.1g, 33mmol) be dissolved in 50mL anhydrous methylene chloride, be cooled to 0 DEG C, add trifluoromethanesulfanhydride anhydride (4.6mL, 33mmol), stir 20 minutes minutes, add freshly prepd 6-chloro-9-pyranyl purine (5.24g, 22mmol), remain on 0 DEG C, react 5 hours, add 100mL saturated sodium bicarbonate solution, stir, separate organic phase, aqueous phase anhydrous methylene chloride extracting twice, collect organic phase, dry, removal of solvent under reduced pressure, obtain pale yellow oil, be the chloro-2-nitro of 6--9-pyranyl purine.
4. a kind of 2-fluoroadenine synthetic method according to claim 1, it is characterized in that, step 3 specifically comprises: with 6-chloro-2-nitro-9-pyranyl purine (5.6g, 20mmol) and NH 4f (1.1g, 30mmol) joins in DMF (50mL), stirring at room temperature, react 10 hours, activated carbon decolorizing, removal of solvent under reduced pressure, the thick substances water recrystallization obtained, obtains white powder, is the fluoro-6-chloropurine of 2-.
5. a kind of 2-fluoroadenine synthetic method according to claim 1, it is characterized in that, step 4 specifically comprises: the fluoro-6-chloropurine (10g of 2-, 58mmol), join in the saturated methanol solution saturated by ammonia of 100mL, be heated to 50 DEG C of reactions 10 hours, cooling, activated carbon decolorizing, removal of solvent under reduced pressure, obtains oily matter, uses water recrystallization, obtain white solid, be 2-fluoroadenine.
CN201510620892.XA 2015-09-25 2015-09-25 A kind of 2 fluoroadenine synthetic methods Active CN105130989B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510620892.XA CN105130989B (en) 2015-09-25 2015-09-25 A kind of 2 fluoroadenine synthetic methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510620892.XA CN105130989B (en) 2015-09-25 2015-09-25 A kind of 2 fluoroadenine synthetic methods

Publications (2)

Publication Number Publication Date
CN105130989A true CN105130989A (en) 2015-12-09
CN105130989B CN105130989B (en) 2017-10-03

Family

ID=54716616

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510620892.XA Active CN105130989B (en) 2015-09-25 2015-09-25 A kind of 2 fluoroadenine synthetic methods

Country Status (1)

Country Link
CN (1) CN105130989B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180130073A (en) * 2017-05-26 2018-12-06 에스티팜 주식회사 The Method For Adenine Derivative
CN112661758A (en) * 2020-12-29 2021-04-16 天津全和诚科技有限责任公司 Preparation method of fludarabine antitumor drug intermediate

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CALLEY N.EATON ET AL.: "Convenient Synthesis of 2-Fluoroadenine", 《THE JOURNAL OF ORGANIC CHEMISTRY》 *
JOHN A.MONTGOMERY ET AL.: "Synthesis of Potential Anticancer Agents.XX.2-Fluoropurines", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 *
ROLAND K.ROBINS ET AL.: "Purine Nucleosides.I.The Synthesis of Certain 6-Substituted-9-(tetrahydro-2-pyrany1)-purines as Models of Purine Deoxynucleosides", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 *
汪江节等: "合成2-氟腺嘌呤的新方法", 《合成化学》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180130073A (en) * 2017-05-26 2018-12-06 에스티팜 주식회사 The Method For Adenine Derivative
KR101930908B1 (en) 2017-05-26 2019-01-24 에스티팜 주식회사 The Method For Adenine Derivative
CN112661758A (en) * 2020-12-29 2021-04-16 天津全和诚科技有限责任公司 Preparation method of fludarabine antitumor drug intermediate

Also Published As

Publication number Publication date
CN105130989B (en) 2017-10-03

Similar Documents

Publication Publication Date Title
RU2011127190A (en) METHOD FOR SYNTHESIS OF NUCLEIC ACIDS MODIFIED BY PHOSPHOR ATOMIC
RU2015151857A (en) METHOD FOR SYNTHESIS OF NUCLEIC ACIDS MODIFIED BY PHOSPHOR ATOMIC
EP3733683A1 (en) Nucleoside analogue, preparation method and application
Gołofit et al. Optimization of potassium dinitramide preparation
CN111704582A (en) Preparation method of Favipiravir and derivatives thereof
Tirumala et al. Self-assembled ionophores. An isoguanosine-K+ octamer
CN105130989A (en) 2-fluoroadenine synthetic method
Francom et al. Nucleic Acid Related Compounds. 118. Nonaqueous Diazotization of Aminopurine Derivatives. Convenient Access to 6-Halo-and 2, 6-Dihalopurine Nucleosides and 2 ‘-Deoxynucleosides with Acyl or Silyl Halides1
WO2017068136A1 (en) 5,5'-bis(2,4,6-trinitrophenyl)-2,2'-bi(1,3,4-oxadiazole) and bis(2,4,6-trinitrobenzoyl)oxalohydrazide
Mandal et al. Optimization of ammonium sulfamate nitration for the preparation of ammonium dinitramide
CN113444039A (en) Method for preparing 2,2, 4-trimethyl-1, 2-dihydroquinoline by using ionic liquid
Il'yasov et al. Preparation of 1, 3‐Diazido‐2‐Nitro‐2‐Azapropane from Urea
Smith et al. Silver-free synthesis of nitrate-containing room-temperature ionic liquids
Sankaranarayanan et al. A numerical and experimental study of the decomposition pathways of guanidinium nitrate
US7057072B2 (en) Synthesis and purification of 1,3,5-triamino-2,4,6-trinitrobenzene (TATB)
Tao et al. The preparation and properties of low-nitrogen nitrocellulose by alkaline denitration
Kusov et al. Direct di-and triamination of polyfluoropyridines in anhydrous ammonia
Kim et al. Synthesis and characterization of a new energy material: Pyridinium dinitramide (Py-DN)
CN115124519A (en) Fluorescent reagent for detecting dimethyl chlorophosphate and preparation method thereof
CN101759761B (en) Method for preparing steroid compounds containing 6alpha-F
Chapyshev Di-and triazidation of 3-chlorotetrafluoropyridine
CN109748930A (en) For detecting the fluorescent probe molecule and its preparation method and application of explosive RDX
Niu et al. Synthesis of Chiral N‐(Purin‐6‐yl) amino Acid Derivatives by using Natural Amino Acids as Starting Materials
CN103694182A (en) Preparation method of quinoxaline compound
KR101264166B1 (en) Method for preparing 1,2-bis(5-aminotetrazol-1-yl)ethane

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant